Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile–Induced Abdominal Aortic Aneurysm
Tatsuo Kawai(University of Iowa), Satoru Eguchi(University of South Florida), Tomonori Kobayashi(Juntendo University), Takashi Obama(Showa Pharmaceutical University), Hang Fai Kwok(University of Macau), Kyle Preston(Temple University), Michael Boyer(Chris O’Brien Lifehouse), Hannah Cooper(Temple University), Rosario Scalia(Thomas Jefferson University), Steven J. Forrester(Emory University), Takehiko Takayanagi(Cornell University), Victor Rizzo(University of Iowa), Toshiyuki Tsuji(Cornell University), Tomoki Hashimoto(Obayashi (Japan))
Cited by 53
Related Papers
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
|Circulation Research|2018|2k